Cargando…

Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population

BACKGROUND AND PURPOSE: Intracerebral Aβ protein deposition is an important pathological mechanism of Alzheimer’s disease (AD) and is one of the indicators of early diagnosis of AD. However, invasive lumbar puncture and Aβ PET are difficult to perform in primary units, resulting delays in early diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yue, Wang, Zhiqiang, Yin, Jiajun, Yang, Bixiu, Fan, Jie, Cheng, Zaohuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420413/ https://www.ncbi.nlm.nih.gov/pubmed/36043117 http://dx.doi.org/10.2147/NDT.S374722

Ejemplares similares

Association of plasma brain-derived neurotrophic factor with Alzheimer’s disease and its influencing factors in Chinese elderly population
por: Qian, Fuqiang, et al.
Publicado: (2022)

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)

Association Analysis of Polymorphisms in BIN1, MC1R, STARD6 and PVRL2 with Mild Cognitive Impairment in Elderly Carrying APOE ε4 Allele
por: Wu, Yue, et al.
Publicado: (2021)

The effects of high plasma levels of Aβ(1-42) on mononuclear macrophage in mouse models of Alzheimer’s disease
por: Li, Chunrong, et al.
Publicado: (2023)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
por: Yin, Jiajun, et al.
Publicado: (2019)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2021)

Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer’s Amyloid β (Aβ(1–42)) Peptide
por: Menon, Sneha, et al.
Publicado: (2017)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels
por: Nakamura, Takumi, et al.
Publicado: (2018)

Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ(42) Protofibrils in Alzheimer’s Disease
por: Söllvander, Sofia, et al.
Publicado: (2015)

Paper-Based Detection Device for Alzheimer’s Disease—Detecting β-amyloid Peptides (1–42) in Human Plasma
por: Sung, Wei-Hsuan, et al.
Publicado: (2020)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Cerebrospinal Fluid Aβ(42/40) Corresponds Better than Aβ(42) to Amyloid PET in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2016)

Effects of Heart Bypass Surgery on Plasma Aβ40 and Aβ42 Levels in Infants and Young Children
por: Hu, Yaoqin, et al.
Publicado: (2016)

Site-specific structural order in Alzheimer's Aβ42 fibrils
por: Wang, Hongsu, et al.
Publicado: (2018)

Effects of Terahertz Radiation on the Aggregation of Alzheimer’s Aβ42 Peptide
por: Wang, Lei, et al.
Publicado: (2023)

Influence of denaturants on amyloid β42 aggregation kinetics
por: Weiffert, Tanja, et al.
Publicado: (2022)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
por: Cheng, Yuan, et al.
Publicado: (2022)

The Validation of Multifactor Model of Plasma Aβ(42) and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease
por: Jiao, Fubin, et al.
Publicado: (2020)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer’s disease
por: Cullen, Nicholas C, et al.
Publicado: (2023)

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
por: Shahpasand-Kroner, Hedieh, et al.
Publicado: (2018)

Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
por: Jäkel, Lieke, et al.
Publicado: (2019)

Oxygen Concentration and Oxidative Stress Modulate the Influence of Alzheimer's Disease Aβ (1–42) Peptide on Human Cells
por: Džinić, Tamara, et al.
Publicado: (2018)

Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
por: Baiardi, Simone, et al.
Publicado: (2018)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

The Unexpected Role of Aβ(1-42) Monomers in the Pathogenesis of Alzheimer’s Disease
por: Tamagno, Elena, et al.
Publicado: (2018)

Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Calcium inhibits penetration of Alzheimer's Aβ(1)–(42) monomers into the membrane
por: Boopathi, Subramanian, et al.
Publicado: (2022)

Synergistic Effect on Neurodegeneration by N-Truncated Aβ(4−42) and Pyroglutamate Aβ(3−42) in a Mouse Model of Alzheimer's Disease
por: Lopez-Noguerola, Jose S., et al.
Publicado: (2018)

Cerebrospinal Fluid β-Amyloid(1–42) Levels in the Differential Diagnosis of Alzheimer’s Disease—Systematic Review and Meta-Analysis
por: Mo, Jin-A, et al.
Publicado: (2015)

Abdominal Obesity: An Independent Influencing Factor of Visuospatial and Executive/Language Ability and the Serum Levels of Aβ40/Aβ42/Tau Protein
por: Fan, Xin, et al.
Publicado: (2022)

Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
por: Lue, Lih-Fen, et al.
Publicado: (2019)

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
por: Michno, Wojciech, et al.
Publicado: (2019)

Dynamic Blood Concentrations of Aβ(1–40) and Aβ(1–42) in Alzheimer’s Disease
por: Yang, Yuan-Han, et al.
Publicado: (2020)

Increased plasma amyloid-β(42) protein in sporadic inclusion body myositis
por: Abdo, Wilson F., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hcj9dchqoi61m039il0ibr7b2t